Attack-related severity: a key factor in understanding the spectrum of idiopathic inflammatory demyelinating disorders

被引:22
作者
Fukazawa, T
Kikuchi, S
Niino, M
Yabe, I
Miyagishi, R
Fukaura, H
Hamada, T
Tashiro, K
Sasaki, H
机构
[1] Hokuyukai Neurol Hosp, Nishi Ku, Sapporo, Hokkaido 0630802, Japan
[2] Hokkaido Univ, Grad Sch Med, Dept Neurol, Kita Ku, Sapporo, Hokkaido 0638638, Japan
[3] Hlth Sci Univ Hokkaido, Sch Psychol Sci, Kita Ku, Sapporo, Hokkaido 0028072, Japan
关键词
multiple sclerosis; immunogenetic background; fulminant attack; opticospinal MS; neuromyelitis optica;
D O I
10.1016/j.jns.2004.07.003
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Understanding the spectrum of idiopathic inflammatory demyelinating disorders (IIDD) is a fundamental issue for the diagnosis and treatment of these disorders as well as for the approach to their pathogenesis. The spectrum of IIDD is usually classified according to clinical course and lesion distribution. We compared the demographic features, clinical characteristics, laboratory findings, and genetic backgrounds between 193 Japanese patients with and without clinically or radiographically fulminant attacks who all satisfied the diagnostic criteria for multiple sclerosis (MS). "Fulminant attacks" in the current study represent attack-related clinically or radiologically severe relapses but do not necessarily mean severe disability. Patients with fulminant attacks were clinically and immunogenetically distinct from those free of such attacks, and the previously described characteristics of the opticospinal form of MS (OSMS) or neuromyelitis optica (NMO) were mostly shared by patients with fulminant attacks. HLA profiles were similar among patients with fulminant attacks irrespective of the lesion distributions. The GG homozygous and G alleles of the CTLA4 gene A/G coding SNP at position 49 in exon 1 were significantly more common in patients with fulminant attacks than in those without. Attack-related severity may be an important factor if validated by prospective studies defining criteria and establishing relationships to disease course and treatment regimens. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:71 / 78
页数:8
相关论文
共 46 条
[11]   Both the HLA-DPB1 and-DRB1 alleles correlate with risk for multiple sclerosis in Japanese: clinical phenotypes and gender as important factors [J].
Fukazawa, T ;
Yamasaki, K ;
Ito, H ;
Kikuchi, S ;
Minohara, M ;
Horiuchi, I ;
Tsukishima, E ;
Sasaki, H ;
Hamada, T ;
Nishimura, Y ;
Tashiro, K ;
Kira, J .
TISSUE ANTIGENS, 2000, 55 (03) :199-205
[12]   Genomic HLA profiles of MS in Hokkaido, Japan: important role of DPB1"0501 allele [J].
Fukazawa, T ;
Kikuchi, S ;
Sasaki, H ;
Yabe, I ;
Miyagishi, R ;
Hamada, T ;
Tashiro, K .
JOURNAL OF NEUROLOGY, 2000, 247 (03) :175-178
[13]  
FUKAZAWA T, 1994, INT MS J, V1, P27
[14]  
Harbo HF, 1999, TISSUE ANTIGENS, V53, P106
[15]  
IKUTA F, 1976, MULTIPLE SCLEROSIS A, P143
[16]  
IKUTA F, 1982, MULTIPLE SCLEROSIS E, P297
[17]   HLA-DP-associated susceptibility to the optico-spinal form of multiple sclerosis in the Japanese [J].
Ito, H ;
Yamasaki, K ;
Kawano, Y ;
Horiuchi, I ;
Yun, C ;
Nishimura, Y ;
Kira, J .
TISSUE ANTIGENS, 1998, 52 (02) :179-182
[18]   HILA-related subpopulations of MS in Japanese with and without oligoclonal IgG bands [J].
Kikuchi, S ;
Fukazawa, T ;
Niino, M ;
Yabe, I ;
Miyagishi, R ;
Hamada, T ;
Hashimoto, SA ;
Tashiro, K .
NEUROLOGY, 2003, 60 (04) :647-651
[19]  
Kira J, 1996, ANN NEUROL, V40, P569
[20]   Changes in the clinical phenotypes of multiple sclerosis during the past 50 years in Japan [J].
Kira, J ;
Yamasaki, K ;
Horiuchi, I ;
Ohyagi, Y ;
Taniwaki, T ;
Kawano, Y .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1999, 166 (01) :53-57